Neratinib Alone or in Combination with Immune Checkpoint Inhibitors with or Without Mammalian Target of Rapamycin Inhibitors in Patients with Fibrolamellar Carcinoma
LIVER CANCER(2024)
Key words
Neratinib,Fibrolamellar carcinoma,SUMMIT phase 2 basket study,Pan-HER kinase inhibition
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined